-
Introducing flexible configuration packages for the Alto Digital SPR System
In today’s challenging economic climate, both biotechs and academic labs are navigating through tough times, particularly when it comes to securing funding for essential equipment and research i...
-
Hello Boston, Meet Nicoya.
We are super excited to introduce our new lab in Boston! Meet the dynamic team behind the launch and discover the capabilities of our innovative instruments. We’re thrilled to share some fantast...
-
Helping scientists succeed in the Bay Area: Meet the team behind our new San Francisco lab
We’re excited to announce the opening of our brand-new lab facility in San Francisco! Meet the team behind this exciting development and explore how we’re supporting drug discovery in the Bay Area...
-
How does Digital SPR fit into early drug discovery?
Digital surface plasmon resonance (SPR) offers a more automated and versatile method for studying binding properties that determine lead quality and drug efficacy. Biomolecular interactions are at the...
-
SPR vs ELISA: Comparing techniques for biomolecular detection
Binding analysis with surface plasmon resonance (SPR) provides both affinity and kinetics data, giving you the bigger picture. As one of the most standardized and well-characterized immunoassays perfo...
-
2022 wrapped: Celebrating 10 years at Nicoya
We took a moment to look back on the key events that shaped this milestone year. By Ryan Denomme, Co-Founder and CEO Quick links A year of milestones What’s new for our users? Learnings from the fie...
-
SPR vs BLI: Comparing label-free tools for Fc receptor characterization
Alto™ streamlines the characterization of Fc gamma receptors in our latest app note comparing analysis with Digital SPR and BLI. Fc receptors (FcR), named for their binding specificity to the fragme...
-
New Nature study reveals insights into de novo autoreactivity in severe COVID-19 using Alto™ Digital SPR
Kinetic analysis of de novo autoreactivity in severe COVID-19 reveals important implications for early intervention and treatment in patients with post-COVID sequelae. The SARS-CoV-2 outbreak was firs...
-
Targeting interleukins: How digital SPR accelerates monoclonal antibodies for immune-related diseases
Alto’s unmatched ability to seamlessly characterize mAbs make it the optimal fit for biologics developers. Read our latest application note on digital SPR analysis of the interleukin-6 receptor (IL-...
-
Application note: Characterization of ImmTAC® bispecific molecules with Alto™ digital SPR
Immunocore’s ImmTAC technology is a novel class of biologics that target cancer cells through T-cell redirecting immunotherapy. Bispecific molecules, or bispecifics, are a growing subset of biothera...
